<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.3 20210610//EN" "JATS-journalpublishing1-3.dtd">
<article article-type="research-article" dtd-version="1.3" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xml:lang="en"><front><journal-meta><journal-id journal-id-type="publisher-id">ejols</journal-id><journal-title-group><journal-title xml:lang="en">The Eurasian Journal of Life Sciences</journal-title><trans-title-group xml:lang="ru"><trans-title>Евразийский журнал наук о жизни</trans-title></trans-title-group></journal-title-group><issn pub-type="ppub">3033-5493</issn><issn pub-type="epub">3033-6031</issn><publisher><publisher-name>Сеченовский Университет</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="doi">10.47093/3033-5493.2025.1.2.36-55</article-id><article-id custom-type="elpub" pub-id-type="custom">ejols-30</article-id><article-categories><subj-group subj-group-type="heading"><subject>Research Article</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="ru"><subject>Статьи</subject></subj-group></article-categories><title-group><article-title>Chronic low-level inflammation in childhood obesity: systematic review and meta-analysis of key biomarkers</article-title><trans-title-group xml:lang="ru"><trans-title>Хроническое субклиническое воспаление при ожирении у детей: систематический обзор и мета-анализ ключевых биомаркеров</trans-title></trans-title-group></title-group><contrib-group><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-5250-7351</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Ковтун</surname><given-names>О. П.</given-names></name><name name-style="western" xml:lang="en"><surname>Kovtun</surname><given-names>O. P.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Ольга Петровна Ковтун, Доктор медицинских наук, Профессор, Академик Российской Академии Наук, Директор Института Фундаментальной Медицины</p><p>ул. Репина, 3, Екатеринбург, 620028</p></bio><bio xml:lang="en"><p>Olga P.Kovtun, Dr. Sci. (Med.), Professor, Academician of the Russian Academy of Sciences, Director, Institute of Fundamental Medicine</p><p>3, Repina str., Yekaterinburg, 620028</p></bio><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-4285-6902</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Устюжанина</surname><given-names>М. А.</given-names></name><name name-style="western" xml:lang="en"><surname>Ustiuzhanina</surname><given-names>M. A.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Маргарита Александровна Устюжанина, Кандидат медицинских наук, Доцент, Кафедра поликлинической педиатрии</p><p>ул. Репина, 3, Екатеринбург, 620028</p></bio><bio xml:lang="en"><p>Margarita A.Ustiuzhanina, Cand. Sci. (Med.), Associate Professor, Department of Outpatient Pediatrics</p><p>3, Repina str., Yekaterinburg, 620028</p></bio><email xlink:type="simple">ustmargarita@mail.ru</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0009-0009-8178-5818</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Флягин</surname><given-names>М. А.</given-names></name><name name-style="western" xml:lang="en"><surname>Fliagin</surname><given-names>M. A.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Михаил Александрович Флягин, Проректор по перспективному развитию и международной деятельности</p><p>ул. Репина, 3, Екатеринбург, 620028</p></bio><bio xml:lang="en"><p>Mikhail A.Fliagin, Vice-Rector for Perspective Development and International Relations</p><p>3, Repina str., Yekaterinburg, 620028</p></bio><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-1262-7383</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Гун</surname><given-names>Чунсю</given-names></name><name name-style="western" xml:lang="en"><surname>Gong</surname><given-names>Chunxiu</given-names></name></name-alternatives><bio xml:lang="ru"><p>Чунсю Гун, Профессор, Почётный директор, Департамент эндокринологии, генетики и метаболизма</p><p>ул. Нанилиши, 56, г. Пекин, 100045</p></bio><bio xml:lang="en"><p>Chunxiu Gong, Professor, Honorary Director, Department of Endocrinology, Genetics and Metabolism</p><p>56, Nanlishi Road, Beijing, 100045</p></bio><xref ref-type="aff" rid="aff-2"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-4122-5818</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Цао</surname><given-names>Бинъянь</given-names></name><name name-style="western" xml:lang="en"><surname>Cao</surname><given-names>Bingyan</given-names></name></name-alternatives><bio xml:lang="ru"><p>Бинъянь Цао, Директор, Отделение эндокринологии</p><p>ул. Ябао, 2, район Чаоян, г. Пекин, 100020</p></bio><bio xml:lang="en"><p>Bingyan Cao, Director, Department of Endocrinology</p><p>2, Yabao Road, Chaoyang District, Beijing 100020</p></bio><xref ref-type="aff" rid="aff-3"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0009-0003-2952-6890</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Доу</surname><given-names>Синьюй</given-names></name><name name-style="western" xml:lang="en"><surname>Dou</surname><given-names>Xinyu</given-names></name></name-alternatives><bio xml:lang="ru"><p>Синьюй Доу, MD, клинический постдок, Департамент эндокринологии, генетики и метаболизма</p><p>ул. Наньлиши, 56, г. Пекин, 100045</p></bio><bio xml:lang="en"><p>Xinyu Dou, MD, clinical postdoctor, Department of Endocrinology, Genetics and Metabolism</p><p>56, Nanlishi Road, Beijing, 100045</p></bio><xref ref-type="aff" rid="aff-2"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-8378-6613</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>И</surname><given-names>Ван</given-names></name><name name-style="western" xml:lang="en"><surname>Yi</surname><given-names>Wang</given-names></name></name-alternatives><bio xml:lang="ru"><p>Ван И, MD, научный сотрудник, Департамент эндокринологии, генетики и метаболизма</p><p>ул. Наньлиши, 56, г. Пекин, 100045</p></bio><bio xml:lang="en"><p>Yi Wang, MD, Fellow, Department of Endocrinology, Genetics and Metabolism</p><p>56, Nanlishi Road, Beijing, 100045</p></bio><xref ref-type="aff" rid="aff-2"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-7929-9820</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Лю</surname><given-names>Мэйцзюань</given-names></name><name name-style="western" xml:lang="en"><surname>Liu</surname><given-names>Meijuan</given-names></name></name-alternatives><bio xml:lang="ru"><p>Мэйцзюань Лю, MD, научный сотрудник, Департамент эндокринологии, генетики и метаболизма</p><p>ул. Наньлиши, 56, г. Пекин, 100045</p></bio><bio xml:lang="en"><p>Meijuan Liu, MD, Fellow, Department of Endocrinology, Genetics and Metabolism</p><p>56, Nanlishi Road, Beijing, 100045</p></bio><xref ref-type="aff" rid="aff-2"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0003-2742-0438</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Чжан</surname><given-names>Цинь</given-names></name><name name-style="western" xml:lang="en"><surname>Zhang</surname><given-names>Qin</given-names></name></name-alternatives><bio xml:lang="ru"><p>Цинь Чжан, MD, клинический постдок, Департамент эндокринологии, генетики и метаболизма</p><p>ул. Наньлиши, 56, г. Пекин, 100045</p></bio><bio xml:lang="en"><p>Qin Zhang, MD, clinical postdoctor, Department of Endocrinology, Genetics and Metabolism</p><p>56, Nanlishi Road, Beijing, 100045</p></bio><xref ref-type="aff" rid="aff-2"/></contrib></contrib-group><aff-alternatives id="aff-1"><aff xml:lang="ru"><institution>ФГБОУ ВО «Уральский государственный медицинский университет» Министерства здравоохранения Российской Федерации</institution></aff><aff xml:lang="en"><institution>Ural State Medical University</institution></aff></aff-alternatives><aff-alternatives id="aff-2"><aff xml:lang="ru"><institution>Пекинская детская больница, Столичный медицинский университет, Национальный центр здоровья детей</institution></aff><aff xml:lang="en"><institution>Beijing Children’s Hospital, Capital Medical University, National Center for Children’s Health</institution></aff></aff-alternatives><aff-alternatives id="aff-3"><aff xml:lang="ru"><institution>Детская больница при Столичном институте педиатрии</institution></aff><aff xml:lang="en"><institution>Children’s Hospital Affiliated to Capital institute of Pediatrics</institution></aff></aff-alternatives><pub-date pub-type="collection"><year>2025</year></pub-date><pub-date pub-type="epub"><day>18</day><month>01</month><year>2026</year></pub-date><volume>1</volume><issue>2</issue><fpage>36</fpage><lpage>55</lpage><permissions><copyright-statement>Copyright &amp;#x00A9; Kovtun O.P., Ustiuzhanina M.A., Fliagin M.A., Gong C., Cao B., Dou X., Yi W., Liu M., Zhang Q., 2026</copyright-statement><copyright-year>2026</copyright-year><copyright-holder xml:lang="ru">Ковтун О.П., Устюжанина М.А., Флягин М.А., Гун Ч., Цао Б., Доу С., И В., Лю М., Чжан Ц.</copyright-holder><copyright-holder xml:lang="en">Kovtun O.P., Ustiuzhanina M.A., Fliagin M.A., Gong C., Cao B., Dou X., Yi W., Liu M., Zhang Q.</copyright-holder><license xml:lang="ru" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>Данная работа распространяется под лицензией Creative Commons Attribution 4.0.</license-p></license><license xml:lang="en" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>This work is licensed under a Creative Commons Attribution 4.0 License.</license-p></license></permissions><self-uri xlink:href="https://www.eajls.com/jour/article/view/30">https://www.eajls.com/jour/article/view/30</self-uri><abstract><p>Childhood obesity is associated with chronic low-level inflammation, which is considered a key mechanism in the development of insulin resistance, dyslipidemia and increased cardiovascular risk. Increased levels of interleukin-6 (IL-6), tumor necrosis factor-α (TNF-α), C-reactive protein (CRP) and high-sensitivity CRP (hs-CRP) have been reported in children with obesity, but research results are contradictory, and pooled quantitative estimates of the levels of these biomarkers for the pediatric population have not yet been conducted.</p><p>The aim of the study was to systematize data on inflammatory biomarkers in children with obesity and to compare their levels quantitatively with control groups.</p><p>A systematic search of publications was conducted in the databases PubMed, Scopus, Web of Science, Semantic Scholar, e-Library and Google Scholar (until August 2025). Observational studies were included in children and adolescents aged 6–18 years with obesity diagnosed according to WHO criteria or national standards, which reported levels of CRP, hs-CRP, IL-6 or TNF-α.</p><p>The meta-analysis included 21 studies with a total of 11,193 participants. Children with obesity showed a significant increase elevated levels of all the inflammatory cytokines studied. The most pronounced difference was noted for CRP, g = −1.30 (95% CI: −2.32; −0.29), whereas hs-CRP, g = −0.70 (95% CI: −1.01; −0.39), IL-6, g = −0.51 (95% CI: −0.80; −0.21) and TNF-α, g = −0.60 (95% CI: −0.97; −0.24) demonstrated moderate, but stable and significant effects.</p><p>To our knowledge, this is the first meta-analysis to summarize data on inflammatory cytokines in children with obesity. hs-CRP showed a more moderate effect size but more stable and reproducible results which make it suitable for clinical use. Importantly, these findings gain additional significance when viewed in the context of studies in adolescents, adults, and the elderly, where dynamic of inflammatory cytokines are associated with subclinical vascular changes, cardiovascular events, and mortality. Elevated levels of these markers in childhood may serve as an early biological signal of long-term cardiometabolic risk.</p></abstract><trans-abstract xml:lang="ru"><p>Ожирение у детей ассоциируется с хроническим субклиническим воспалением, которое считают ключевым механизмом в развитии инсулинорезистентности, дислипидемии и повышении риска сердечно-сосудистых заболеваний. Повышенные содержание интерлейкина-6 (ИЛ-6), фактора некроза опухоли-α (ФНО-α), C-реактивного белка (CРБ) и высокочувствительного CRP (ВЧ-CРБ) отмечены у детей с ожирением. Однако результаты исследований противоречивы, а обобщенные количественные оценки уровней этих биомаркеров для детской популяции до сих пор не проводили.</p><p>Целью исследования была систематизация данных о воспалительных биомаркерах у детей с ожирением и сравнение их количественного содержания с контрольными группами.</p><p>Проведен систематический поиск публикаций в базах данных PubMed, Scopus, Web of Science, Semantic Scholar, e-Library и Google Scholar (до августа 2025 г.). В анализ включили наблюдательные исследования с участием детей и подростков в возрасте 6–18 лет с ожирением, диагностированным согласно критериям ВОЗ или национальным стандартам, в которых определяли CРБ, ВЧ-CРБ, ИЛ-6 или ФНО-α.</p><p>В мета-анализ вошло 21 исследование с 11 193 участниками в общей сложности. У детей с ожирением выявили достоверное повышение уровней всех изученных воспалительных цитокинов. Наиболее выраженная разница отмечена для CРБ, g = −1,30 (95% ДИ: от −2,32 до −0,29), тогда как для остальных биомаркеров отмечен умеренный, но стабильный и статистически значимые различия: ВЧ-CРБ, g = −0,70 (95% ДИ: от −1,01 до −0,39), ИЛ-6, g = −0,51 (95% ДИ: от −0,80 до −0,21) и ФНО-α, g = −0,60 (95% ДИ: от −0,97 до −0,24).</p><p>Насколько нам известно, это первый мета-анализ, обобщающий данные о воспалительных цитокинах у детей с ожирением. При анализе содержания ВЧ-CРБ отметили наиболее умеренную величину эффекта, и более стабильные и воспроизводимые результаты, что делает этот биомаркер ценным для клинического применения. Важно, что эти данные также ценны в контексте исследований в популяции подростков, взрослых и пожилых людей, где динамика воспалительных цитокинов ассоциирована с субклиническими сосудистыми изменениями, сердечно-сосудистыми событиями и смертностью. Повышенные уровни изученных маркеров в детском возрасте могут служить ранним биологическим сигналом долгосрочного кардиометаболического риска.</p></trans-abstract><kwd-group xml:lang="ru"><kwd>ребёнок</kwd><kwd>подросток</kwd><kwd>педиатрия</kwd><kwd>хроническое заболевание</kwd><kwd>ранняя диагностика</kwd></kwd-group><kwd-group xml:lang="en"><kwd>child</kwd><kwd>adolescent</kwd><kwd>pediatric</kwd><kwd>chronic disease</kwd><kwd>early diagnostic</kwd></kwd-group></article-meta></front><back><ref-list><title>References</title><ref id="cit1"><label>1</label><citation-alternatives><mixed-citation xml:lang="ru">Zhao X, Niu Y, Zhao XL, et al. Associations Between Serum TNF-α, IL-6, hs-CRP and GLMD in Obese Children and Adolescents: A Cross-Sectional Study. Diabetes Metab Syndr Obes. 2023;16:3915-3923. https://doi.org/10.2147/DMSO.S434482.</mixed-citation><mixed-citation xml:lang="en">Zhao X, Niu Y, Zhao XL, et al. Associations Between Serum TNF-α, IL-6, hs-CRP and GLMD in Obese Children and Adolescents: A Cross-Sectional Study. Diabetes Metab Syndr Obes. 2023;16:3915-3923. https://doi.org/10.2147/DMSO.S434482.</mixed-citation></citation-alternatives></ref><ref id="cit2"><label>2</label><citation-alternatives><mixed-citation xml:lang="ru">Dinov D, Khait A. Inflammatory markers in relation to pre-pubertal obesity. J Immunol. 2018;200(Supplement_1):106.3. https://doi.org/10.4049/jimmunol.200.Supp.106.3.</mixed-citation><mixed-citation xml:lang="en">Dinov D, Khait A. Inflammatory markers in relation to pre-pubertal obesity. J Immunol. 2018;200(Supplement_1):106.3. https://doi.org/10.4049/jimmunol.200.Supp.106.3.</mixed-citation></citation-alternatives></ref><ref id="cit3"><label>3</label><citation-alternatives><mixed-citation xml:lang="ru">Selvaraju V, Babu JR, Geetha T. Association of salivary C-reactive protein with the obesity measures and markers in children. Diabetes Metab Syndr Obes Targets Ther. 2019;12:1239-1247. https://doi.org/10.2147/DMSO.S211624.</mixed-citation><mixed-citation xml:lang="en">Selvaraju V, Babu JR, Geetha T. Association of salivary C-reactive protein with the obesity measures and markers in children. Diabetes Metab Syndr Obes Targets Ther. 2019;12:1239-1247. https://doi.org/10.2147/DMSO.S211624.</mixed-citation></citation-alternatives></ref><ref id="cit4"><label>4</label><citation-alternatives><mixed-citation xml:lang="ru">Yang SP, Gong CX, Cao BY, Yan C. [Relationship between serum high-sensitivity C-reactive protein and obesity and impaired glycose metabolism in children and adolescents]. Zhonghua Er Ke Za Zhi. 2006;44(12):933-936 (In Chinese).</mixed-citation><mixed-citation xml:lang="en">Yang SP, Gong CX, Cao BY, Yan C. [Relationship between serum high-sensitivity C-reactive protein and obesity and impaired glycose metabolism in children and adolescents]. Zhonghua Er Ke Za Zhi. 2006;44(12):933-936 (In Chinese).</mixed-citation></citation-alternatives></ref><ref id="cit5"><label>5</label><citation-alternatives><mixed-citation xml:lang="ru">Mărginean CO, Meliţ LE, Huțanu A, Ghiga DV, Săsăran MO. The adipokines and inflammatory status in the era of pediatric obesity. Cytokine. 2020;126:154925. https://doi.org/10.1016/j.cyto.2019.154925.</mixed-citation><mixed-citation xml:lang="en">Mărginean CO, Meliţ LE, Huțanu A, Ghiga DV, Săsăran MO. The adipokines and inflammatory status in the era of pediatric obesity. Cytokine. 2020;126:154925. https://doi.org/10.1016/j.cyto.2019.154925.</mixed-citation></citation-alternatives></ref><ref id="cit6"><label>6</label><citation-alternatives><mixed-citation xml:lang="ru">Engin A. The Pathogenesis of Obesity-Associated Adipose Tissue Inflammation. In: Engin AB, Engin A, eds. Obesity and Lipotoxicity. Vol 960. Advances in Experimental Medicine and Biology. Springer International Publishing. 2017:221-245. https://doi.org/10.1007/978-3-319-48382-5_9.</mixed-citation><mixed-citation xml:lang="en">Engin A. The Pathogenesis of Obesity-Associated Adipose Tissue Inflammation. In: Engin AB, Engin A, eds. Obesity and Lipotoxicity. Vol 960. Advances in Experimental Medicine and Biology. Springer International Publishing. 2017:221-245. https://doi.org/10.1007/978-3-319-48382-5_9.</mixed-citation></citation-alternatives></ref><ref id="cit7"><label>7</label><citation-alternatives><mixed-citation xml:lang="ru">Podeanu MA, Turcu-Stiolica A, Subțirelu MS, et al. C-Reactive Protein as a Marker of Inflammation in Children and Adolescents with Metabolic Syndrome: A Systematic Review and Meta-Analysis. Biomedicines. 2023;11(11):2961. https://doi.org/10.3390/biomedicines11112961.</mixed-citation><mixed-citation xml:lang="en">Podeanu MA, Turcu-Stiolica A, Subțirelu MS, et al. C-Reactive Protein as a Marker of Inflammation in Children and Adolescents with Metabolic Syndrome: A Systematic Review and Meta-Analysis. Biomedicines. 2023;11(11):2961. https://doi.org/10.3390/biomedicines11112961.</mixed-citation></citation-alternatives></ref><ref id="cit8"><label>8</label><citation-alternatives><mixed-citation xml:lang="ru">Bizjak DA, Ammerpohl O, Schulz SVw, Wendt J, Steinacker JM, Flechtner-Mors M. Pro-inflammatory and (Epi-)genetic markers in saliva for disease risk in childhood obesity. Nutr Metab Cardiovasc Dis. 2022;32(6):1502-1510. https://doi.org/10.1016/j.numecd.2022.03.016.</mixed-citation><mixed-citation xml:lang="en">Bizjak DA, Ammerpohl O, Schulz SVw, Wendt J, Steinacker JM, Flechtner-Mors M. Pro-inflammatory and (Epi-)genetic markers in saliva for disease risk in childhood obesity. Nutr Metab Cardiovasc Dis. 2022;32(6):1502-1510. https://doi.org/10.1016/j.numecd.2022.03.016.</mixed-citation></citation-alternatives></ref><ref id="cit9"><label>9</label><citation-alternatives><mixed-citation xml:lang="ru">Goehring KC, Marriage BJ, Oliver JS, Wilder JA, Barrett EG, Buck RH. Similar to Those Who Are Breastfed, Infants Fed a Formula Containing 2′-Fucosyllactose Have Lower Inflammatory Cytokines in a Randomized Controlled Trial. J Nutr. 2016;146(12):2559-2566. https://doi.org/10.3945/jn.116.236919.</mixed-citation><mixed-citation xml:lang="en">Goehring KC, Marriage BJ, Oliver JS, Wilder JA, Barrett EG, Buck RH. Similar to Those Who Are Breastfed, Infants Fed a Formula Containing 2′-Fucosyllactose Have Lower Inflammatory Cytokines in a Randomized Controlled Trial. J Nutr. 2016;146(12):2559-2566. https://doi.org/10.3945/jn.116.236919.</mixed-citation></citation-alternatives></ref><ref id="cit10"><label>10</label><citation-alternatives><mixed-citation xml:lang="ru">Gough A, Sitch A, Ferris E, Marshall T. Within-subject variation of C-reactive protein and high-sensitivity C-reactive protein: A systematic review and meta-analysis. PLOS ONE. 2024;19(11):e0304961. https://doi.org/10.1371/journal.pone.0304961.</mixed-citation><mixed-citation xml:lang="en">Gough A, Sitch A, Ferris E, Marshall T. Within-subject variation of C-reactive protein and high-sensitivity C-reactive protein: A systematic review and meta-analysis. PLOS ONE. 2024;19(11):e0304961. https://doi.org/10.1371/journal.pone.0304961.</mixed-citation></citation-alternatives></ref><ref id="cit11"><label>11</label><citation-alternatives><mixed-citation xml:lang="ru">Gul A, Yilmaz R. Determination of inflammation by TNF-alpha and IL-10 levels in obese children and adolescents. Nutr Hosp. 2024;41(4):788-792. https://doi.org/10.20960/nh.05064.</mixed-citation><mixed-citation xml:lang="en">Gul A, Yilmaz R. Determination of inflammation by TNF-alpha and IL-10 levels in obese children and adolescents. Nutr Hosp. 2024;41(4):788-792. https://doi.org/10.20960/nh.05064.</mixed-citation></citation-alternatives></ref><ref id="cit12"><label>12</label><citation-alternatives><mixed-citation xml:lang="ru">World Health Organization. Training Course on Child Growth Assessment. Geneva, WHO, 2008. ISBN 92 4 159507 8; ISBN 978 92 4 159507 0.</mixed-citation><mixed-citation xml:lang="en">World Health Organization. Training Course on Child Growth Assessment. Geneva, WHO, 2008. ISBN 92 4 159507 8; ISBN 978 92 4 159507 0.</mixed-citation></citation-alternatives></ref><ref id="cit13"><label>13</label><citation-alternatives><mixed-citation xml:lang="ru">Cole TJ. Establishing a standard definition for child overweight and obesity worldwide: international survey. BMJ. 2000;320(7244):1240. https://doi.org/10.1136/bmj.320.7244.1240.</mixed-citation><mixed-citation xml:lang="en">Cole TJ. Establishing a standard definition for child overweight and obesity worldwide: international survey. BMJ. 2000;320(7244):1240. https://doi.org/10.1136/bmj.320.7244.1240.</mixed-citation></citation-alternatives></ref><ref id="cit14"><label>14</label><citation-alternatives><mixed-citation xml:lang="ru">Kuczmarski RJ, Ogden CL, Guo SS, et al. 2000 CDC Growth Charts for the United States: methods and development. Vital Health Stat 11. 2002;(246):1-190.</mixed-citation><mixed-citation xml:lang="en">Kuczmarski RJ, Ogden CL, Guo SS, et al. 2000 CDC Growth Charts for the United States: methods and development. Vital Health Stat 11. 2002;(246):1-190.</mixed-citation></citation-alternatives></ref><ref id="cit15"><label>15</label><citation-alternatives><mixed-citation xml:lang="ru">Khadilkar VV, Khadilkar AV, Borade AB, Chiplonkar SA. Body mass index cut-offs for screening for childhood overweight and obesity in Indian children. Indian Pediatr. 2012;49(1):29-34. https://doi.org/10.1007/s13312-012-0011-y.</mixed-citation><mixed-citation xml:lang="en">Khadilkar VV, Khadilkar AV, Borade AB, Chiplonkar SA. Body mass index cut-offs for screening for childhood overweight and obesity in Indian children. Indian Pediatr. 2012;49(1):29-34. https://doi.org/10.1007/s13312-012-0011-y.</mixed-citation></citation-alternatives></ref><ref id="cit16"><label>16</label><citation-alternatives><mixed-citation xml:lang="ru">Wan X, Wang W, Liu J, Tong T. Estimating the sample mean and standard deviation from the sample size, median, range and/or interquartile range. BMC Med Res Methodol. 2014;14(1):135. https://doi.org/10.1186/1471-2288-14-135.</mixed-citation><mixed-citation xml:lang="en">Wan X, Wang W, Liu J, Tong T. Estimating the sample mean and standard deviation from the sample size, median, range and/or interquartile range. BMC Med Res Methodol. 2014;14(1):135. https://doi.org/10.1186/1471-2288-14-135.</mixed-citation></citation-alternatives></ref><ref id="cit17"><label>17</label><citation-alternatives><mixed-citation xml:lang="ru">Gallardo-Gómez D, Richardson R, Dwan K. Standardized mean differences in meta-analysis: A tutorial. Cochrane Evid Synth Methods. 2024;2(3):e12047. https://doi.org/10.1002/cesm.12047.</mixed-citation><mixed-citation xml:lang="en">Gallardo-Gómez D, Richardson R, Dwan K. Standardized mean differences in meta-analysis: A tutorial. Cochrane Evid Synth Methods. 2024;2(3):e12047. https://doi.org/10.1002/cesm.12047.</mixed-citation></citation-alternatives></ref><ref id="cit18"><label>18</label><citation-alternatives><mixed-citation xml:lang="ru">Aleman MN, Luciardi MC, Albornoz ER, Bazán MC, Abregú AV. Relationship between inflammatory biomarkers and insulin resistance in excess-weight Latin children. Clin Exp Pediatr. 2024;67(1):37-45. https://doi.org/10.3345/cep.2022.01382.</mixed-citation><mixed-citation xml:lang="en">Aleman MN, Luciardi MC, Albornoz ER, Bazán MC, Abregú AV. Relationship between inflammatory biomarkers and insulin resistance in excess-weight Latin children. Clin Exp Pediatr. 2024;67(1):37-45. https://doi.org/10.3345/cep.2022.01382.</mixed-citation></citation-alternatives></ref><ref id="cit19"><label>19</label><citation-alternatives><mixed-citation xml:lang="ru">Gokulakrishnan R, Delhikumar CG, Senthilkumar GP, Sahoo J, Kumar RR. Chronic Inflammatory Markers in Overweight and Obese Children: A Cross-sectional Analytical Study. Indian J Endocrinol Metab. 2024;28(5):542-547. https://doi.org/10.4103/ijem.ijem_353_23.</mixed-citation><mixed-citation xml:lang="en">Gokulakrishnan R, Delhikumar CG, Senthilkumar GP, Sahoo J, Kumar RR. Chronic Inflammatory Markers in Overweight and Obese Children: A Cross-sectional Analytical Study. Indian J Endocrinol Metab. 2024;28(5):542-547. https://doi.org/10.4103/ijem.ijem_353_23.</mixed-citation></citation-alternatives></ref><ref id="cit20"><label>20</label><citation-alternatives><mixed-citation xml:lang="ru">Kassem E, Na’amnih W, Shapira M, Ornoy A, Muhsen K. Comparison between School-Age Children with and without Obesity in Nutritional and Inflammation Biomarkers. J Clin Med. 2022;11(23):6973. https://doi.org/10.3390/jcm11236973.</mixed-citation><mixed-citation xml:lang="en">Kassem E, Na’amnih W, Shapira M, Ornoy A, Muhsen K. Comparison between School-Age Children with and without Obesity in Nutritional and Inflammation Biomarkers. J Clin Med. 2022;11(23):6973. https://doi.org/10.3390/jcm11236973.</mixed-citation></citation-alternatives></ref><ref id="cit21"><label>21</label><citation-alternatives><mixed-citation xml:lang="ru">Cura–Esquivel I, Perales-Quintana MM, Torres-González L, Guzmán-Avilán K, MuñozEspinosa L, Cordero-Pérez P. Metabolic, inflammatory and adipokine differences on overweight/obese children with and without metabolic syndrome: A cross-sectional study. PLOS ONE. 2023;18(3):e0281381. https://doi.org/10.1371/journal.pone.0281381.</mixed-citation><mixed-citation xml:lang="en">Cura–Esquivel I, Perales-Quintana MM, Torres-González L, Guzmán-Avilán K, MuñozEspinosa L, Cordero-Pérez P. Metabolic, inflammatory and adipokine differences on overweight/obese children with and without metabolic syndrome: A cross-sectional study. PLOS ONE. 2023;18(3):e0281381. https://doi.org/10.1371/journal.pone.0281381.</mixed-citation></citation-alternatives></ref><ref id="cit22"><label>22</label><citation-alternatives><mixed-citation xml:lang="ru">Skvortsova OV, Migacheva NB, Mikhaylova EG. Biomarkers of chronic inflammation in children with obesity and their association with complications of the disease. Russ Pediatr J. 2025;28(1):47-53. https://doi.org/10.46563/1560-9561-2025-28-1-47-53.</mixed-citation><mixed-citation xml:lang="en">Skvortsova OV, Migacheva NB, Mikhaylova EG. Biomarkers of chronic inflammation in children with obesity and their association with complications of the disease. Russ Pediatr J. 2025;28(1):47-53. https://doi.org/10.46563/1560-9561-2025-28-1-47-53.</mixed-citation></citation-alternatives></ref><ref id="cit23"><label>23</label><citation-alternatives><mixed-citation xml:lang="ru">Lang H, Loudermilk EN, Clark WA, et al. Inflammatory markers and body mass index amoung hispanic children. PLOS ONE. 2024;19(6):e0289523. https://doi.org/10.1371/journal.pone.0289523.</mixed-citation><mixed-citation xml:lang="en">Lang H, Loudermilk EN, Clark WA, et al. Inflammatory markers and body mass index amoung hispanic children. PLOS ONE. 2024;19(6):e0289523. https://doi.org/10.1371/journal.pone.0289523.</mixed-citation></citation-alternatives></ref><ref id="cit24"><label>24</label><citation-alternatives><mixed-citation xml:lang="ru">Podeanu MA, Vintilescu Ștefănița B, Sandu RE, et al. Ferritin as an Inflammatory Marker in Pediatric Metabolic Syndrome: Links to Obesity and Liver Ultrasound Alterations. Int J Mol Sci. 2025;26(8):3793. https://doi.org/10.3390/ijms26083793.</mixed-citation><mixed-citation xml:lang="en">Podeanu MA, Vintilescu Ștefănița B, Sandu RE, et al. Ferritin as an Inflammatory Marker in Pediatric Metabolic Syndrome: Links to Obesity and Liver Ultrasound Alterations. Int J Mol Sci. 2025;26(8):3793. https://doi.org/10.3390/ijms26083793.</mixed-citation></citation-alternatives></ref><ref id="cit25"><label>25</label><citation-alternatives><mixed-citation xml:lang="ru">Mărginean CO, Meliţ LE, Ghiga DV, Mărginean MO. Early Inflammatory Status Related to Pediatric Obesity. Front Pediatr. 2019;7:241. https://doi.org/10.3389/fped.2019.00241.</mixed-citation><mixed-citation xml:lang="en">Mărginean CO, Meliţ LE, Ghiga DV, Mărginean MO. Early Inflammatory Status Related to Pediatric Obesity. Front Pediatr. 2019;7:241. https://doi.org/10.3389/fped.2019.00241.</mixed-citation></citation-alternatives></ref><ref id="cit26"><label>26</label><citation-alternatives><mixed-citation xml:lang="ru">Fernández-Vallejo B, Monteagudo FJ, Romero L, Aznárez MIL, Cobas MDCR, Pérez-Martínez L. Cross-Sectional Analysis of IL-6, TNF-α, Adiponectin, Leptin, and Klotho Serum Levels in Relation to BMI Among Overweight and Obese Children Aged 10–14 in La Rioja, Spain. Children. 2025;12(1):89. https://doi.org/10.3390/children12010089.</mixed-citation><mixed-citation xml:lang="en">Fernández-Vallejo B, Monteagudo FJ, Romero L, Aznárez MIL, Cobas MDCR, Pérez-Martínez L. Cross-Sectional Analysis of IL-6, TNF-α, Adiponectin, Leptin, and Klotho Serum Levels in Relation to BMI Among Overweight and Obese Children Aged 10–14 in La Rioja, Spain. Children. 2025;12(1):89. https://doi.org/10.3390/children12010089.</mixed-citation></citation-alternatives></ref><ref id="cit27"><label>27</label><citation-alternatives><mixed-citation xml:lang="ru">Giordano P, Del Vecchio GC, Cecinati V, et al. Metabolic, inflammatory, endothelial and haemostatic markers in a group of Italian obese children and adolescents. Eur J Pediatr. 2011;170(7):845-850. https://doi.org/10.1007/s00431-010-1356-7.</mixed-citation><mixed-citation xml:lang="en">Giordano P, Del Vecchio GC, Cecinati V, et al. Metabolic, inflammatory, endothelial and haemostatic markers in a group of Italian obese children and adolescents. Eur J Pediatr. 2011;170(7):845-850. https://doi.org/10.1007/s00431-010-1356-7.</mixed-citation></citation-alternatives></ref><ref id="cit28"><label>28</label><citation-alternatives><mixed-citation xml:lang="ru">Chavira-Suárez E, Rosel-Pech C, Polo-Oteyza E, et al. Simultaneous evaluation of metabolomic and inflammatory biomarkers in children with different body mass index (BMI) and waist-to-height ratio (WHtR). PLOS ONE. 2020;15(8):e0237917. https://doi.org/10.1371/journal.pone.0237917.</mixed-citation><mixed-citation xml:lang="en">Chavira-Suárez E, Rosel-Pech C, Polo-Oteyza E, et al. Simultaneous evaluation of metabolomic and inflammatory biomarkers in children with different body mass index (BMI) and waist-to-height ratio (WHtR). PLOS ONE. 2020;15(8):e0237917. https://doi.org/10.1371/journal.pone.0237917.</mixed-citation></citation-alternatives></ref><ref id="cit29"><label>29</label><citation-alternatives><mixed-citation xml:lang="ru">Yasin J, Sharma C, Hashim MJ, Al Hamed S, AlKaabi J, Aburawi EH. Cross-Sectional Association Between Body Fat Composition and Biomarkers of Inflammation and Endothelial Dysfunction in Children with Overweight/Obesity. Diabetes Metab Syndr Obes. 2023;16:483-493. https://doi.org/10.2147/DMSO.S390071.</mixed-citation><mixed-citation xml:lang="en">Yasin J, Sharma C, Hashim MJ, Al Hamed S, AlKaabi J, Aburawi EH. Cross-Sectional Association Between Body Fat Composition and Biomarkers of Inflammation and Endothelial Dysfunction in Children with Overweight/Obesity. Diabetes Metab Syndr Obes. 2023;16:483-493. https://doi.org/10.2147/DMSO.S390071.</mixed-citation></citation-alternatives></ref><ref id="cit30"><label>30</label><citation-alternatives><mixed-citation xml:lang="ru">Christaki EV, Pervanidou P, Papassotiriou I, et al. Stress, Inflammation and Metabolic Biomarkers Are Associated with Body Composition Measures in Lean, Overweight, and Obese Children and Adolescents. Children. 2022;9(2):291. https://doi.org/10.3390/children9020291.</mixed-citation><mixed-citation xml:lang="en">Christaki EV, Pervanidou P, Papassotiriou I, et al. Stress, Inflammation and Metabolic Biomarkers Are Associated with Body Composition Measures in Lean, Overweight, and Obese Children and Adolescents. Children. 2022;9(2):291. https://doi.org/10.3390/children9020291.</mixed-citation></citation-alternatives></ref><ref id="cit31"><label>31</label><citation-alternatives><mixed-citation xml:lang="ru">Simoes E, Correia-Lima J, Sardas L, et al. Sex dimorphism in inflammatory response to obesity in childhood. Int J Obes. 2021;45(4):879-887. https://doi.org/10.1038/s41366-021-00753-1.</mixed-citation><mixed-citation xml:lang="en">Simoes E, Correia-Lima J, Sardas L, et al. Sex dimorphism in inflammatory response to obesity in childhood. Int J Obes. 2021;45(4):879-887. https://doi.org/10.1038/s41366-021-00753-1.</mixed-citation></citation-alternatives></ref><ref id="cit32"><label>32</label><citation-alternatives><mixed-citation xml:lang="ru">Wolters M, Foraita R, Moreno LA, et al. Longitudinal associations between vitamin D status and biomarkers of inflammation in a pan-European cohort of children and adolescents. Eur J Nutr. 2024;63(8):3047-3060. https://doi.org/10.1007/s00394-024-03488-7.</mixed-citation><mixed-citation xml:lang="en">Wolters M, Foraita R, Moreno LA, et al. Longitudinal associations between vitamin D status and biomarkers of inflammation in a pan-European cohort of children and adolescents. Eur J Nutr. 2024;63(8):3047-3060. https://doi.org/10.1007/s00394-024-03488-7.</mixed-citation></citation-alternatives></ref><ref id="cit33"><label>33</label><citation-alternatives><mixed-citation xml:lang="ru">Tam CS, Garnett SP, Cowell CT, et al. IL-6, IL-8 and IL-10 Levels in Healthy Weight and Overweight Children. Horm Res Paediatr. 2010;73(2):128-134. https://doi.org/10.1159/000277632.</mixed-citation><mixed-citation xml:lang="en">Tam CS, Garnett SP, Cowell CT, et al. IL-6, IL-8 and IL-10 Levels in Healthy Weight and Overweight Children. Horm Res Paediatr. 2010;73(2):128-134. https://doi.org/10.1159/000277632.</mixed-citation></citation-alternatives></ref><ref id="cit34"><label>34</label><citation-alternatives><mixed-citation xml:lang="ru">Lund MAV, Thostrup AH, Frithioff-Bøjsøe C, et al. Low-grade inflammation independently associates with cardiometabolic risk in children with overweight/obesity. Nutr Metab Cardiovasc Dis. 2020;30(9):1544-1553. https://doi.org/10.1016/j.numecd.2020.04.024.</mixed-citation><mixed-citation xml:lang="en">Lund MAV, Thostrup AH, Frithioff-Bøjsøe C, et al. Low-grade inflammation independently associates with cardiometabolic risk in children with overweight/obesity. Nutr Metab Cardiovasc Dis. 2020;30(9):1544-1553. https://doi.org/10.1016/j.numecd.2020.04.024.</mixed-citation></citation-alternatives></ref><ref id="cit35"><label>35</label><citation-alternatives><mixed-citation xml:lang="ru">Chang CJ, Jian DY, Lin MW, Zhao JZ, Ho LT, Juan CC. Evidence in Obese Children: Contribution of Hyperlipidemia, Obesity-Inflammation, and Insulin Sensitivity. PLOS ONE. 2015;10(5):e0125935. https://doi.org/10.1371/journal.pone.0125935.</mixed-citation><mixed-citation xml:lang="en">Chang CJ, Jian DY, Lin MW, Zhao JZ, Ho LT, Juan CC. Evidence in Obese Children: Contribution of Hyperlipidemia, Obesity-Inflammation, and Insulin Sensitivity. PLOS ONE. 2015;10(5):e0125935. https://doi.org/10.1371/journal.pone.0125935.</mixed-citation></citation-alternatives></ref><ref id="cit36"><label>36</label><citation-alternatives><mixed-citation xml:lang="ru">Juliaty A, Kurniasih D. Inflammatory markers and lipid profiles in obese children. Paediatr Indones. 2021;61(5):271-276. https://doi.org/10.14238/pi61.5.2021.271-6.</mixed-citation><mixed-citation xml:lang="en">Juliaty A, Kurniasih D. Inflammatory markers and lipid profiles in obese children. Paediatr Indones. 2021;61(5):271-276. https://doi.org/10.14238/pi61.5.2021.271-6.</mixed-citation></citation-alternatives></ref><ref id="cit37"><label>37</label><citation-alternatives><mixed-citation xml:lang="ru">Maffeis L, Agostoni CV, Marafon DP, et al. Cytokines Profile and Lung Function in Children with Obesity and Asthma: A Case Control Study. Children. 2022;9(10):1462. https://doi.org/10.3390/children9101462.</mixed-citation><mixed-citation xml:lang="en">Maffeis L, Agostoni CV, Marafon DP, et al. Cytokines Profile and Lung Function in Children with Obesity and Asthma: A Case Control Study. Children. 2022;9(10):1462. https://doi.org/10.3390/children9101462.</mixed-citation></citation-alternatives></ref><ref id="cit38"><label>38</label><citation-alternatives><mixed-citation xml:lang="ru">Choi J, Joseph L, Pilote L. Obesity and C-reactive protein in various populations: a systematic review and meta-analysis. Obes Rev. 2013;14(3):232-244. https://doi.org/10.1111/obr.12003.</mixed-citation><mixed-citation xml:lang="en">Choi J, Joseph L, Pilote L. Obesity and C-reactive protein in various populations: a systematic review and meta-analysis. Obes Rev. 2013;14(3):232-244. https://doi.org/10.1111/obr.12003.</mixed-citation></citation-alternatives></ref><ref id="cit39"><label>39</label><citation-alternatives><mixed-citation xml:lang="ru">Zhao Y, Lv G. Correlation of C-reactive protein level and obesity in Chinese adults and children: a meta-analysis. J Endocrinol Invest. 2013;36(8):642-647. https://doi.org/10.3275/9004.</mixed-citation><mixed-citation xml:lang="en">Zhao Y, Lv G. Correlation of C-reactive protein level and obesity in Chinese adults and children: a meta-analysis. J Endocrinol Invest. 2013;36(8):642-647. https://doi.org/10.3275/9004.</mixed-citation></citation-alternatives></ref><ref id="cit40"><label>40</label><citation-alternatives><mixed-citation xml:lang="ru">Dragoumani K, Troumbis A, Bacopoulou F, Chrousos G. Childhood and Adolescent Obesity with Somatic Indicators of Stress, Inflammation, and Dysmetabolism before and after Intervention: A Meta-Analysis. J Pers Med. 2023;13(9):1322. https://doi.org/10.3390/jpm13091322.</mixed-citation><mixed-citation xml:lang="en">Dragoumani K, Troumbis A, Bacopoulou F, Chrousos G. Childhood and Adolescent Obesity with Somatic Indicators of Stress, Inflammation, and Dysmetabolism before and after Intervention: A Meta-Analysis. J Pers Med. 2023;13(9):1322. https://doi.org/10.3390/jpm13091322.</mixed-citation></citation-alternatives></ref><ref id="cit41"><label>41</label><citation-alternatives><mixed-citation xml:lang="ru">Bujtor M, Turner A, Torres S, Esteban-Gonzalo L, Pariante C, Borsini A. Associations of Dietary Intake on Biological Markers of Inflammation in Children and Adolescents: A Systematic Review. Nutrients. 2021;13(2):356. https://doi.org/10.3390/nu13020356.</mixed-citation><mixed-citation xml:lang="en">Bujtor M, Turner A, Torres S, Esteban-Gonzalo L, Pariante C, Borsini A. Associations of Dietary Intake on Biological Markers of Inflammation in Children and Adolescents: A Systematic Review. Nutrients. 2021;13(2):356. https://doi.org/10.3390/nu13020356.</mixed-citation></citation-alternatives></ref><ref id="cit42"><label>42</label><citation-alternatives><mixed-citation xml:lang="ru">Berton PF, Gambero A. Hepcidin and inflammation associated with iron deficiency in childhood obesity – A systematic review. J Pediatr (Rio J). 2024;100(2):124-131. https://doi.org/10.1016/j.jped.2023.06.002.</mixed-citation><mixed-citation xml:lang="en">Berton PF, Gambero A. Hepcidin and inflammation associated with iron deficiency in childhood obesity – A systematic review. J Pediatr (Rio J). 2024;100(2):124-131. https://doi.org/10.1016/j.jped.2023.06.002.</mixed-citation></citation-alternatives></ref><ref id="cit43"><label>43</label><citation-alternatives><mixed-citation xml:lang="ru">Skinner AC, Steiner MJ, Henderson FW, Perrin EM. Multiple Markers of Inflammation and Weight Status: Cross-sectional Analyses Throughout Childhood. Pediatrics. 2010;125(4):e801-e809. https://doi.org/10.1542/peds.2009-2182.</mixed-citation><mixed-citation xml:lang="en">Skinner AC, Steiner MJ, Henderson FW, Perrin EM. Multiple Markers of Inflammation and Weight Status: Cross-sectional Analyses Throughout Childhood. Pediatrics. 2010;125(4):e801-e809. https://doi.org/10.1542/peds.2009-2182.</mixed-citation></citation-alternatives></ref><ref id="cit44"><label>44</label><citation-alternatives><mixed-citation xml:lang="ru">Tam CS, Clément K, Baur LA, Tordjman J. Obesity and low-grade inflammation: a paediatric perspective. Obes Rev. 2010;11(2):118-126. https://doi.org/10.1111/j.1467-789X.2009.00674.x.</mixed-citation><mixed-citation xml:lang="en">Tam CS, Clément K, Baur LA, Tordjman J. Obesity and low-grade inflammation: a paediatric perspective. Obes Rev. 2010;11(2):118-126. https://doi.org/10.1111/j.1467-789X.2009.00674.x.</mixed-citation></citation-alternatives></ref><ref id="cit45"><label>45</label><citation-alternatives><mixed-citation xml:lang="ru">Zatterale F, Longo M, Naderi J, et al. Chronic Adipose Tissue Inflammation Linking Obesity to Insulin Resistance and Type 2 Diabetes. Front Physiol. 2020;10:1607. https://doi.org/10.3389/fphys.2019.01607.</mixed-citation><mixed-citation xml:lang="en">Zatterale F, Longo M, Naderi J, et al. Chronic Adipose Tissue Inflammation Linking Obesity to Insulin Resistance and Type 2 Diabetes. Front Physiol. 2020;10:1607. https://doi.org/10.3389/fphys.2019.01607.</mixed-citation></citation-alternatives></ref><ref id="cit46"><label>46</label><citation-alternatives><mixed-citation xml:lang="ru">Khanna D, Khanna S, Khanna P, Kahar P, Patel BM. Obesity: A Chronic Low-Grade Inflammation and Its Markers. Cureus. 2022;14(2):e22711. https://doi.org/10.7759/cureus.22711.</mixed-citation><mixed-citation xml:lang="en">Khanna D, Khanna S, Khanna P, Kahar P, Patel BM. Obesity: A Chronic Low-Grade Inflammation and Its Markers. Cureus. 2022;14(2):e22711. https://doi.org/10.7759/cureus.22711.</mixed-citation></citation-alternatives></ref><ref id="cit47"><label>47</label><citation-alternatives><mixed-citation xml:lang="ru">Gasmi A, Noor S, Menzel A, Doşa A, Pivina L, Bjørklund G. Obesity and Insulin Resistance: Associations with Chronic Inflammation, Genetic and Epigenetic Factors. Curr Med Chem. 2021;28(4):800-826. https://doi.org/10.2174/0929867327666200824112056.</mixed-citation><mixed-citation xml:lang="en">Gasmi A, Noor S, Menzel A, Doşa A, Pivina L, Bjørklund G. Obesity and Insulin Resistance: Associations with Chronic Inflammation, Genetic and Epigenetic Factors. Curr Med Chem. 2021;28(4):800-826. https://doi.org/10.2174/0929867327666200824112056.</mixed-citation></citation-alternatives></ref><ref id="cit48"><label>48</label><citation-alternatives><mixed-citation xml:lang="ru">Weijie Z, Meng Z, Chunxiao W, et al. Obesity-induced chronic low-grade inflammation in adipose tissue: A pathway to Alzheimer’s disease. Ageing Res Rev. 2024;99:102402. https://doi.org/10.1016/j.arr.2024.102402.</mixed-citation><mixed-citation xml:lang="en">Weijie Z, Meng Z, Chunxiao W, et al. Obesity-induced chronic low-grade inflammation in adipose tissue: A pathway to Alzheimer’s disease. Ageing Res Rev. 2024;99:102402. https://doi.org/10.1016/j.arr.2024.102402.</mixed-citation></citation-alternatives></ref><ref id="cit49"><label>49</label><citation-alternatives><mixed-citation xml:lang="ru">Rowicka G, Dyląg H, Chełchowska M, Weker H, Ambroszkiewicz J. Serum Calprotectin and Chemerin Concentrations as Markers of Low-Grade Inflammation in Prepubertal Children with Obesity. Int J Environ Res Public Health. 2020;17(20):7575. https://doi.org/10.3390/ijerph17207575.</mixed-citation><mixed-citation xml:lang="en">Rowicka G, Dyląg H, Chełchowska M, Weker H, Ambroszkiewicz J. Serum Calprotectin and Chemerin Concentrations as Markers of Low-Grade Inflammation in Prepubertal Children with Obesity. Int J Environ Res Public Health. 2020;17(20):7575. https://doi.org/10.3390/ijerph17207575.</mixed-citation></citation-alternatives></ref><ref id="cit50"><label>50</label><citation-alternatives><mixed-citation xml:lang="ru">Agbaje AO, Barmi S, Sansum KM, Baynard T, Barker AR, Tuomainen TP. Temporal causal longitudinal associations of high-sensitivity C-reactive protein with carotid intima-media thickness progression in adolescents: the ALSPAC birth cohort study. Eur Heart J. 2022;43(Supplement_2):ehac544.2246. https://doi.org/10.1093/eurheartj/ehac544.2246.</mixed-citation><mixed-citation xml:lang="en">Agbaje AO, Barmi S, Sansum KM, Baynard T, Barker AR, Tuomainen TP. Temporal causal longitudinal associations of high-sensitivity C-reactive protein with carotid intima-media thickness progression in adolescents: the ALSPAC birth cohort study. Eur Heart J. 2022;43(Supplement_2):ehac544.2246. https://doi.org/10.1093/eurheartj/ehac544.2246.</mixed-citation></citation-alternatives></ref><ref id="cit51"><label>51</label><citation-alternatives><mixed-citation xml:lang="ru">Tragomalou A, Paltoglou G, Manou M, et al. Non-Traditional Cardiovascular Risk Factors in Adolescents with Obesity and Metabolic Syndrome May Predict Future Cardiovascular Disease. Nutrients. 2023;15(20):4342. https://doi.org/10.3390/nu15204342.</mixed-citation><mixed-citation xml:lang="en">Tragomalou A, Paltoglou G, Manou M, et al. Non-Traditional Cardiovascular Risk Factors in Adolescents with Obesity and Metabolic Syndrome May Predict Future Cardiovascular Disease. Nutrients. 2023;15(20):4342. https://doi.org/10.3390/nu15204342.</mixed-citation></citation-alternatives></ref><ref id="cit52"><label>52</label><citation-alternatives><mixed-citation xml:lang="ru">Choi EJ, Lee HA, Park B, et al. Trajectory patterns for continuous metabolic syndrome score in childhood and the cardiovascular risk in adolescence. Sci Rep. 2021;11(1):22564. https://doi.org/10.1038/s41598-021-01566-y.</mixed-citation><mixed-citation xml:lang="en">Choi EJ, Lee HA, Park B, et al. Trajectory patterns for continuous metabolic syndrome score in childhood and the cardiovascular risk in adolescence. Sci Rep. 2021;11(1):22564. https://doi.org/10.1038/s41598-021-01566-y.</mixed-citation></citation-alternatives></ref><ref id="cit53"><label>53</label><citation-alternatives><mixed-citation xml:lang="ru">Posadas-Sánchez R, López-Uribe ÁR, Reyes-Barrera J, Ramírez-Bello J, Martínez-Alvarado MDR, Vargas-Alarcón G. Increased carotid intima-media thickness and cardiometabolic risk factors are associated with IL-6 gene polymorphisms in Mexican individuals: The Genetics of Atherosclerotic Disease Mexican study. Biomol Biomed. 2024;24(2):315-322. https://doi.org/10.17305/bb.2023.9495.</mixed-citation><mixed-citation xml:lang="en">Posadas-Sánchez R, López-Uribe ÁR, Reyes-Barrera J, Ramírez-Bello J, Martínez-Alvarado MDR, Vargas-Alarcón G. Increased carotid intima-media thickness and cardiometabolic risk factors are associated with IL-6 gene polymorphisms in Mexican individuals: The Genetics of Atherosclerotic Disease Mexican study. Biomol Biomed. 2024;24(2):315-322. https://doi.org/10.17305/bb.2023.9495.</mixed-citation></citation-alternatives></ref><ref id="cit54"><label>54</label><citation-alternatives><mixed-citation xml:lang="ru">Palhares HMDC, Da Silva AP, Tomé JM, et al. Alterations in the inflammatory markers of the Tumor Necrosis Factor system in overweight and obese children and adolescents. PLOS One. 2025;20(5):e0319832. https://doi.org/10.1371/journal.pone.0319832.</mixed-citation><mixed-citation xml:lang="en">Palhares HMDC, Da Silva AP, Tomé JM, et al. Alterations in the inflammatory markers of the Tumor Necrosis Factor system in overweight and obese children and adolescents. PLOS One. 2025;20(5):e0319832. https://doi.org/10.1371/journal.pone.0319832.</mixed-citation></citation-alternatives></ref><ref id="cit55"><label>55</label><citation-alternatives><mixed-citation xml:lang="ru">Carrero JJ, Andersson Franko M, Obergfell A, Gabrielsen A, Jernberg T. hsCRP Level and the Risk of Death or Recurrent Cardiovascular Events in Patients With Myocardial Infarction: a Healthcare-Based Study. J Am Heart Assoc. 2019;8(11):e012638. https://doi.org/10.1161/JAHA.119.012638.</mixed-citation><mixed-citation xml:lang="en">Carrero JJ, Andersson Franko M, Obergfell A, Gabrielsen A, Jernberg T. hsCRP Level and the Risk of Death or Recurrent Cardiovascular Events in Patients With Myocardial Infarction: a Healthcare-Based Study. J Am Heart Assoc. 2019;8(11):e012638. https://doi.org/10.1161/JAHA.119.012638.</mixed-citation></citation-alternatives></ref><ref id="cit56"><label>56</label><citation-alternatives><mixed-citation xml:lang="ru">Mani P, Puri R, Schwartz GG, et al. Association of Initial and Serial C-Reactive Protein Levels With Adverse Cardiovascular Events and Death After Acute Coronary Syndrome: A Secondary Analysis of the VISTA-16 Trial. JAMA Cardiol. 2019;4(4):314. https://doi.org/10.1001/jamacardio.2019.0179.</mixed-citation><mixed-citation xml:lang="en">Mani P, Puri R, Schwartz GG, et al. Association of Initial and Serial C-Reactive Protein Levels With Adverse Cardiovascular Events and Death After Acute Coronary Syndrome: A Secondary Analysis of the VISTA-16 Trial. JAMA Cardiol. 2019;4(4):314. https://doi.org/10.1001/jamacardio.2019.0179.</mixed-citation></citation-alternatives></ref><ref id="cit57"><label>57</label><citation-alternatives><mixed-citation xml:lang="ru">Katamine M, Minami Y, Nagata T, et al. High-sensitivity C-reactive protein, plaque vulnerability and adverse events in patients with stable coronary disease: An optical coherence tomography study. Int J Cardiol. 2025;421:132924. https://doi.org/10.1016/j.ijcard.2024.132924.</mixed-citation><mixed-citation xml:lang="en">Katamine M, Minami Y, Nagata T, et al. High-sensitivity C-reactive protein, plaque vulnerability and adverse events in patients with stable coronary disease: An optical coherence tomography study. Int J Cardiol. 2025;421:132924. https://doi.org/10.1016/j.ijcard.2024.132924.</mixed-citation></citation-alternatives></ref><ref id="cit58"><label>58</label><citation-alternatives><mixed-citation xml:lang="ru">Opotowsky AR, Valente AM, Alshawabkeh L, et al. Prospective cohort study of C-reactive protein as a predictor of clinical events in adults with congenital heart disease: results of the Boston adult congenital heart disease biobank. Eur Heart J. 2018;39(34):3253-3261. https://doi.org/10.1093/eurheartj/ehy362.</mixed-citation><mixed-citation xml:lang="en">Opotowsky AR, Valente AM, Alshawabkeh L, et al. Prospective cohort study of C-reactive protein as a predictor of clinical events in adults with congenital heart disease: results of the Boston adult congenital heart disease biobank. Eur Heart J. 2018;39(34):3253-3261. https://doi.org/10.1093/eurheartj/ehy362.</mixed-citation></citation-alternatives></ref><ref id="cit59"><label>59</label><citation-alternatives><mixed-citation xml:lang="ru">Held C, White HD, Stewart RAH, et al. Inflammatory Biomarkers Interleukin-6 and C-Reactive Protein and Outcomes in Stable Coronary Heart Disease: Experiences From the STABILITY (Stabilization of Atherosclerotic Plaque by Initiation of Darapladib Therapy) Trial. J Am Heart Assoc. 2017;6(10):e005077. https://doi.org/10.1161/JAHA.116.005077.</mixed-citation><mixed-citation xml:lang="en">Held C, White HD, Stewart RAH, et al. Inflammatory Biomarkers Interleukin-6 and C-Reactive Protein and Outcomes in Stable Coronary Heart Disease: Experiences From the STABILITY (Stabilization of Atherosclerotic Plaque by Initiation of Darapladib Therapy) Trial. J Am Heart Assoc. 2017;6(10):e005077. https://doi.org/10.1161/JAHA.116.005077.</mixed-citation></citation-alternatives></ref><ref id="cit60"><label>60</label><citation-alternatives><mixed-citation xml:lang="ru">Batra G, Ghukasyan Lakic T, Lindbäck J, et al. Interleukin 6 and Cardiovascular Outcomes in Patients With Chronic Kidney Disease and Chronic Coronary Syndrome. JAMA Cardiol. 2021;6(12):1440. https://doi.org/10.1001/jamacardio.2021.3079.</mixed-citation><mixed-citation xml:lang="en">Batra G, Ghukasyan Lakic T, Lindbäck J, et al. Interleukin 6 and Cardiovascular Outcomes in Patients With Chronic Kidney Disease and Chronic Coronary Syndrome. JAMA Cardiol. 2021;6(12):1440. https://doi.org/10.1001/jamacardio.2021.3079.</mixed-citation></citation-alternatives></ref><ref id="cit61"><label>61</label><citation-alternatives><mixed-citation xml:lang="ru">Jia X, Buckley L, Sun C, et al. Association of interleukin-6 and interleukin-18 with cardiovascular disease in older adults: Atherosclerosis Risk in Communities study. Eur J Prev Cardiol. 2023;30(16):1731-1740. https://doi.org/10.1093/eurjpc/zwad197.</mixed-citation><mixed-citation xml:lang="en">Jia X, Buckley L, Sun C, et al. Association of interleukin-6 and interleukin-18 with cardiovascular disease in older adults: Atherosclerosis Risk in Communities study. Eur J Prev Cardiol. 2023;30(16):1731-1740. https://doi.org/10.1093/eurjpc/zwad197.</mixed-citation></citation-alternatives></ref><ref id="cit62"><label>62</label><citation-alternatives><mixed-citation xml:lang="ru">Ridker PM, Rifai N, Pfeffer M, Sacks F, Lepage S, Braunwald E. Elevation of Tumor Necrosis Factor-α and Increased Risk of Recurrent Coronary Events After Myocardial Infarction. Circulation. 2000;101(18):2149-2153. https://doi.org/10.1161/01.CIR.101.18.2149.</mixed-citation><mixed-citation xml:lang="en">Ridker PM, Rifai N, Pfeffer M, Sacks F, Lepage S, Braunwald E. Elevation of Tumor Necrosis Factor-α and Increased Risk of Recurrent Coronary Events After Myocardial Infarction. Circulation. 2000;101(18):2149-2153. https://doi.org/10.1161/01.CIR.101.18.2149.</mixed-citation></citation-alternatives></ref><ref id="cit63"><label>63</label><citation-alternatives><mixed-citation xml:lang="ru">Cui G, Wang H, Li R, et al. Polymorphism of tumor necrosis factor alpha (TNF-alpha) gene promoter, circulating TNF-alpha level, and cardiovascular risk factor for ischemic stroke. J Neuroinflammation. 2012;9(1):235. https://doi.org/10.1186/1742-2094-9-235.</mixed-citation><mixed-citation xml:lang="en">Cui G, Wang H, Li R, et al. Polymorphism of tumor necrosis factor alpha (TNF-alpha) gene promoter, circulating TNF-alpha level, and cardiovascular risk factor for ischemic stroke. J Neuroinflammation. 2012;9(1):235. https://doi.org/10.1186/1742-2094-9-235.</mixed-citation></citation-alternatives></ref><ref id="cit64"><label>64</label><citation-alternatives><mixed-citation xml:lang="ru">Morange PE, Tregouet DA, Godefroy T, et al. Polymorphisms of the tumor necrosis factor-alpha (TNF) and the TNF-alpha converting enzyme (TACE/ADAM17) genes in relation to cardiovascular mortality: the AtheroGene study. J Mol Med. 2008;86(10):1153-1161. https://doi.org/10.1007/s00109-008-0375-6.</mixed-citation><mixed-citation xml:lang="en">Morange PE, Tregouet DA, Godefroy T, et al. Polymorphisms of the tumor necrosis factor-alpha (TNF) and the TNF-alpha converting enzyme (TACE/ADAM17) genes in relation to cardiovascular mortality: the AtheroGene study. J Mol Med. 2008;86(10):1153-1161. https://doi.org/10.1007/s00109-008-0375-6.</mixed-citation></citation-alternatives></ref><ref id="cit65"><label>65</label><citation-alternatives><mixed-citation xml:lang="ru">Liu Y, Zhang C, Jiang L, et al. Relationship Between High-Sensitivity C-Reactive Protein and Long-Term Outcomes in Elderly Patients With 3-Vessel Disease. Angiology. 2022;73(1):60-67. https://doi.org/10.1177/00033197211021195.</mixed-citation><mixed-citation xml:lang="en">Liu Y, Zhang C, Jiang L, et al. Relationship Between High-Sensitivity C-Reactive Protein and Long-Term Outcomes in Elderly Patients With 3-Vessel Disease. Angiology. 2022;73(1):60-67. https://doi.org/10.1177/00033197211021195.</mixed-citation></citation-alternatives></ref><ref id="cit66"><label>66</label><citation-alternatives><mixed-citation xml:lang="ru">Li ZH, Zhong WF, Lv YB, et al. Associations of plasma high-sensitivity C-reactive protein concentrations with all-cause and cause-specific mortality among middle-aged and elderly individuals. Immun Ageing. 2019;16(1):28. https://doi.org/10.1186/s12979-019-0168-5.</mixed-citation><mixed-citation xml:lang="en">Li ZH, Zhong WF, Lv YB, et al. Associations of plasma high-sensitivity C-reactive protein concentrations with all-cause and cause-specific mortality among middle-aged and elderly individuals. Immun Ageing. 2019;16(1):28. https://doi.org/10.1186/s12979-019-0168-5.</mixed-citation></citation-alternatives></ref><ref id="cit67"><label>67</label><citation-alternatives><mixed-citation xml:lang="ru">Kuoppamäki M, Salminen M, Vahlberg T, Irjala K, Kivelä SL, Räihä I. High sensitive C-reactive protein (hsCRP), cardiovascular events and mortality in the aged: A prospective 9-year follow-up study. Arch Gerontol Geriatr. 2015;60(1):112-117. https://doi.org/10.1016/j.archger.2014.10.002.</mixed-citation><mixed-citation xml:lang="en">Kuoppamäki M, Salminen M, Vahlberg T, Irjala K, Kivelä SL, Räihä I. High sensitive C-reactive protein (hsCRP), cardiovascular events and mortality in the aged: A  prospective 9-year follow-up study. Arch Gerontol Geriatr. 2015;60(1):112-117. https://doi.org/10.1016/j.archger.2014.10.002.</mixed-citation></citation-alternatives></ref><ref id="cit68"><label>68</label><citation-alternatives><mixed-citation xml:lang="ru">Li H, Liu W, Xie J. Circulating interleukin-6 levels and cardiovascular and all-cause mortality in the elderly population: A meta-analysis. Arch Gerontol Geriatr. 2017;73:257-262. https://doi.org/10.1016/j.archger.2017.08.007.</mixed-citation><mixed-citation xml:lang="en">Li H, Liu W, Xie J. Circulating interleukin-6 levels and cardiovascular and all-cause mortality in the elderly population: A meta-analysis. Arch Gerontol Geriatr. 2017;73:257-262. https://doi.org/10.1016/j.archger.2017.08.007.</mixed-citation></citation-alternatives></ref><ref id="cit69"><label>69</label><citation-alternatives><mixed-citation xml:lang="ru">Bruunsgaard H, Andersen-Ranberg K, Hjelmborg J v.B, Pedersen BK, Jeune B. Elevated levels of tumor necrosis factor alpha and mortality in centenarians. Am J Med. 2003;115(4):278-283. https://doi.org/10.1016/s0002-9343(03)00329-2.</mixed-citation><mixed-citation xml:lang="en">Bruunsgaard H, Andersen-Ranberg K, Hjelmborg J v.B, Pedersen BK, Jeune B. Elevated levels of tumor necrosis factor alpha and mortality in centenarians. Am J Med. 2003;115(4):278-283. https://doi.org/10.1016/s0002-9343(03)00329-2.</mixed-citation></citation-alternatives></ref></ref-list><fn-group><fn fn-type="conflict"><p>The authors declare that there are no conflicts of interest present.</p></fn></fn-group></back></article>
